HEALTH● LOW2h ago · Oct 3, 2026, 6:37 PM
AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot
Seeking Alpha Tech · global
Several major pharmaceutical companies, including AbbVie, Amgen, Pfizer, and GSK, are participating in a new 340B rebate pilot program. This indicates a development in pharmaceutical pricing and healthcare policy involving key industry players.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH10m ago11-year-old cancer survivor shares his storyCBS NewsHEALTH1h agoIllinois catering business ordered to shut down after high school football team got sick before homecomingThe Independent WorldHEALTH2h agoMexican father and son win the race of life against heart diseaseClarínHEALTH2h agoFlorida’s dengue outbreak reportedly largest US has seen in decadesThe Hill